Ascidian Therapeutics Announces Three Key Development Team Appointments as It Advances Its Lead Program Toward the Clinic

/PRNewswire/ -- Ascidian Therapeutics, a biotechnology company focused on treating human diseases by rewriting RNA, announced today three new appointments to...

Related Keywords

United States ,Boston ,Massachusetts ,United Kingdom ,Carmen Jacome ,Jaya Barth ,Sarah Disalvatore ,Stanford University ,Ear Harvard Medical School ,York Medical College ,Program Management ,Genentech ,University Of South Carolina ,Clinical Development ,Genetic Technologies Corporation ,Salisbury University ,Gx Foundation ,Pfizer ,Novartis ,Emory University ,University Of Birmingham ,Darla Moore School Of Business ,Community Advocacy Committee For Simons Searchlight ,Vice President ,Clinical Operations ,Chief Medical Officer ,Clinical Development Lead ,Editas Medicine ,Massachusetts Eye ,Harvard Medical School ,Applied Genetic Technologies Corporation ,Assistant Vice President ,Rocket Pharma ,Stemline Therapeutics ,Investigational New Drugs ,Leadership Advisory Board ,Community Advocacy Committee ,Simons Searchlight ,New York Medical ,Flexion Therapeutics ,Darla Moore School ,Ascidian Therapeutics ,